The abstract is read at the publisher; the summary is JClub's.
Covalent chemoproteomics and structural data identified ligandable cysteines, tyrosines, and lysines on interferonopathy-associated proteins, including ligandable sites on ADAR1, RNASEH2A, and SAMHD1.
- Why it matters: Mendelian type I interferonopathies involve genetic mutations that upregulate interferon signalling, and small-molecule modulators could support anti-tumour immunity, but suitable probes and drugs are lacking.
- What they did: The study compiled covalent chemoproteomics and structural information to map ligandable residues across diverse interferonopathy-linked proteins, highlighting actionable targets such as ADAR1, RNASEH2A, and SAMHD1.
- The result: The resulting ligandability resource enables future drug discovery aimed at immunotherapeutics by providing specific, actionable protein sites for chemical probe and small-molecule development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.